| Year |
Citation |
Score |
| 2012 |
Quilichini PP, Le Van Quyen M, Ivanov A, Turner DA, Carabalona A, Gozlan H, Esclapez M, Bernard C. Hub GABA neurons mediate gamma-frequency oscillations at ictal-like event onset in the immature hippocampus. Neuron. 74: 57-64. PMID 22500630 DOI: 10.1016/J.Neuron.2012.01.026 |
0.675 |
|
| 2006 |
Quilichini PP, Chiron C, Ben-Ari Y, Gozlan H. Stiripentol, a putative antiepileptic drug, enhances the duration of opening of GABA-A receptor channels. Epilepsia. 47: 704-16. PMID 16650136 DOI: 10.1111/J.1528-1167.2006.00497.X |
0.696 |
|
| 2005 |
Khalilov I, Le Van Quyen M, Gozlan H, Ben-Ari Y. Epileptogenic actions of GABA and fast oscillations in the developing hippocampus. Neuron. 48: 787-96. PMID 16337916 DOI: 10.1016/J.Neuron.2005.09.026 |
0.428 |
|
| 2005 |
Bernard C, Milh M, Morozov YM, Ben-Ari Y, Freund TF, Gozlan H. Altering cannabinoid signaling during development disrupts neuronal activity. Proceedings of the National Academy of Sciences of the United States of America. 102: 9388-93. PMID 15964987 DOI: 10.1073/Pnas.0409641102 |
0.374 |
|
| 2004 |
Ben-Ari Y, Khalilov I, Represa A, Gozlan H. Interneurons set the tune of developing networks. Trends in Neurosciences. 27: 422-7. PMID 15219742 DOI: 10.1016/J.Tins.2004.05.002 |
0.321 |
|
| 2003 |
Quilichini PP, Diabira D, Chiron C, Milh M, Ben-Ari Y, Gozlan H. Effects of antiepileptic drugs on refractory seizures in the intact immature corticohippocampal formation in vitro. Epilepsia. 44: 1365-74. PMID 14636342 DOI: 10.1046/J.1528-1157.2003.19503.X |
0.684 |
|
| 2003 |
Gozlan H, Ben-Ari Y. Interneurons are the source and the targets of the first synapses formed in the rat developing hippocampal circuit. Cerebral Cortex (New York, N.Y. : 1991). 13: 684-92. PMID 12764045 DOI: 10.1093/Cercor/13.6.684 |
0.326 |
|
| 2002 |
Quilichini PP, Diabira D, Chiron C, Ben-Ari Y, Gozlan H. Persistent epileptiform activity induced by low Mg2+ in intact immature brain structures. The European Journal of Neuroscience. 16: 850-60. PMID 12372021 DOI: 10.1046/J.1460-9568.2002.02143.X |
0.674 |
|
| 2002 |
Hennou S, Khalilov I, Diabira D, Ben-Ari Y, Gozlan H. Early sequential formation of functional GABA(A) and glutamatergic synapses on CA1 interneurons of the rat foetal hippocampus. The European Journal of Neuroscience. 16: 197-208. PMID 12169102 DOI: 10.1046/J.1460-9568.2002.02073.X |
0.35 |
|
| 2001 |
Gaïarsa JL, Khalilov I, Gozlan H, Ben-Ari Y. Morphology of CA3 non-pyramidal cells in the developing rat hippocampus. Brain Research. Developmental Brain Research. 127: 157-64. PMID 11335002 DOI: 10.1016/S0165-3806(01)00130-4 |
0.316 |
|
| 2000 |
Rafiki A, Bernard A, Medina I, Gozlan H, Khrestchatisky M. Characterization in cultured cerebellar granule cells and in the developing rat brain of mRNA variants for the NMDA receptor 2C subunit. Journal of Neurochemistry. 74: 1798-808. PMID 10800922 DOI: 10.1046/J.1471-4159.2000.0741798.X |
0.352 |
|
| 1999 |
Diabira D, Hennou S, Chevassus-Au-Louis N, Ben-Ari Y, Gozlan H. Late embryonic expression of AMPA receptor function in the CA1 region of the intact hippocampus in vitro. The European Journal of Neuroscience. 11: 4015-23. PMID 10583490 DOI: 10.1046/J.1460-9568.1999.00831.X |
0.423 |
|
| 1999 |
Tyzio R, Represa A, Jorquera I, Ben-Ari Y, Gozlan H, Aniksztejn L. The establishment of GABAergic and glutamatergic synapses on CA1 pyramidal neurons is sequential and correlates with the development of the apical dendrite. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 19: 10372-82. PMID 10575034 DOI: 10.1523/Jneurosci.19-23-10372.1999 |
0.341 |
|
| 1998 |
Crépel V, Congar P, Aniksztejn L, Gozlan H, Hammond C, Ben-Ari Y. Synaptic plasticity in ischemia: role of NMDA receptors. Progress in Brain Research. 116: 273-85. PMID 9932383 DOI: 10.1016/S0079-6123(08)60443-4 |
0.358 |
|
| 1997 |
Debray C, Diabira D, Gaiarsa JL, Ben-Ari Y, Gozlan H. Contributions of AMPA and GABA(A) receptors to the induction of NMDAR-dependent LTP in CA1. Neuroscience Letters. 238: 119-22. PMID 9464634 DOI: 10.1016/S0304-3940(97)00865-3 |
0.39 |
|
| 1997 |
Lanfumey L, Haj-Dahmane S, Laporte AM, Martin P, Hamon M, Gozlan H. Effects of chronic diazepam treatment on pre- and postsynaptic 5-HT1A receptors in the rat brain. European Journal of Pharmacology. 323: 137-48. PMID 9128832 DOI: 10.1016/S0014-2999(97)00032-0 |
0.426 |
|
| 1997 |
Quesada O, Hirsch JC, Gozlan H, Ben-Ari Y, Bernard C. Epileptiform activity but not synaptic plasticity is blocked by oxidation of NMDA receptors in a chronic model of temporal lobe epilepsy. Epilepsy Research. 26: 373-80. PMID 9095399 DOI: 10.1016/S0920-1211(96)01004-2 |
0.379 |
|
| 1997 |
Rafiki A, Gozlan H, Ben-Ari Y, Khrestchatisky M, Medina I. The calcium-dependent transient inactivation of recombinant NMDA receptor-channel does not involve the high affinity calmodulin binding site of the NR1 subunit. Neuroscience Letters. 223: 137-9. PMID 9089692 DOI: 10.1016/S0304-3940(97)13413-9 |
0.376 |
|
| 1996 |
Hirsch JC, Quesada O, Esclapez M, Gozlan H, Ben-Ari Y, Bernard CL. Enhanced NMDAR-dependent epileptiform activity is controlled by oxidizing agents in a chronic model of temporal lobe epilepsy. Journal of Neurophysiology. 76: 4185-9. PMID 8985912 DOI: 10.1152/Jn.1996.76.6.4185 |
0.378 |
|
| 1996 |
Fletcher A, Forster EA, Bill DJ, Brown G, Cliffe IA, Hartley JE, Jones DE, McLenachan A, Stanhope KJ, Critchley DJ, Childs KJ, Middlefell VC, Lanfumey L, Corradetti R, Laporte AM, ... Gozlan H, et al. Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist. Behavioural Brain Research. 73: 337-53. PMID 8788530 DOI: 10.1016/0166-4328(96)00118-0 |
0.478 |
|
| 1996 |
Gozlan H, Ben-Ari Y. NMDA and GABA(A) receptors, NO and redox modulation Trends in Pharmacological Sciences. 17: 187-189. DOI: 10.1016/0165-6147(96)81597-5 |
0.366 |
|
| 1995 |
Gozlan H, Ben-Ari Y. NMDA receptor redox sites: are they targets for selective neuronal protection? Trends in Pharmacological Sciences. 16: 368-74. PMID 8578605 DOI: 10.1016/S0165-6147(00)89077-X |
0.385 |
|
| 1995 |
Göthert M, Hamon M, Barann M, Bönisch H, Gozlan H, Laguzzi R, Metzenauer P, Nickel B, Szelenyi I. 5-HT3 receptor antagonism by anpirtoline, a mixed 5-HT1 receptor agonist/5-HT3 receptor antagonist. British Journal of Pharmacology. 114: 269-74. PMID 7881726 DOI: 10.1111/J.1476-5381.1995.Tb13222.X |
0.337 |
|
| 1995 |
Gozlan H, Khazipov R, Ben-Ari Y. Multiple forms of long-term potentiation and multiple regulatory sites of N-methyl-D-aspartate receptors: role of the redox site. Journal of Neurobiology. 26: 360-9. PMID 7775969 DOI: 10.1002/Neu.480260308 |
0.362 |
|
| 1995 |
Gozlan H, Thibault S, Laporte AM, Lima L, Hamon M. The selective 5-HT1A antagonist radioligand [3H]WAY 100635 labels both G-protein-coupled and free 5-HT1A receptors in rat brain membranes. European Journal of Pharmacology. 288: 173-86. PMID 7720779 DOI: 10.1016/0922-4106(95)90192-2 |
0.399 |
|
| 1995 |
Gozlan H, Khazipov R, Diabira D, Ben-Ari Y. In CA1 hippocampal neurons, the redox state of NMDA receptors determines LTP expressed by NMDA but not by AMPA receptors. Journal of Neurophysiology. 73: 2612-7. PMID 7666170 DOI: 10.1152/Jn.1995.73.6.2612 |
0.365 |
|
| 1995 |
Ben-Ari Y, Khazipov R, Gozlan H. The redox site of NMDA receptors controls LTP expressed by NMDA — but not by AMPA — receptors Pharmacological Research. 31: 153. DOI: 10.1016/1043-6618(95)86872-0 |
0.338 |
|
| 1994 |
Jolas T, Haj-Dahmane S, Kidd EJ, Langlois X, Lanfumey L, Fattaccini CM, Vantalon V, Laporte AM, Adrien J, Gozlan H. Central pre- and postsynaptic 5-HT1A receptors in rats treated chronically with a novel antidepressant, cericlamine. The Journal of Pharmacology and Experimental Therapeutics. 268: 1432-43. PMID 8138956 |
0.385 |
|
| 1994 |
Haj-Dahmane S, Jolas T, Laporte AM, Gozlan H, Farré AJ, Hamon M, Lanfumey L. Interactions of lesopitron (E-4424) with central 5-HT1A receptors: in vitro and in vivo studies in the rat. European Journal of Pharmacology. 255: 185-96. PMID 8026543 DOI: 10.1016/0014-2999(94)90097-3 |
0.453 |
|
| 1994 |
Gozlan H, Laporte AM, Thibault S, Schechter LE, Bolaños F, Hamon M. Differential effects of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) on various 5-HT receptor binding sites in the rat brain. Neuropharmacology. 33: 423-31. PMID 7984280 DOI: 10.1016/0028-3908(94)90072-8 |
0.467 |
|
| 1994 |
Gozlan H, Diabira D, Chinestra P, Ben-Ari Y. Anoxic LTP is mediated by the redox modulatory site of the NMDA receptor. Journal of Neurophysiology. 72: 3017-22. PMID 7897507 DOI: 10.1152/Jn.1994.72.6.3017 |
0.37 |
|
| 1994 |
Gérard C, Langlois X, Gingrich J, Doucet E, Vergé D, Kia HK, Raisman R, Gozlan H, el Mestikawy S, Hamon M. Production and characterization of polyclonal antibodies recognizing the intracytoplasmic third loop of the 5-hydroxytryptamine1A receptor. Neuroscience. 62: 721-39. PMID 7870302 DOI: 10.1016/0306-4522(94)90472-3 |
0.414 |
|
| 1994 |
Gozlan H, Chinestra P, Diabira D, Ben-Ari Y. NMDA redox site modulates long-term potentiation of NMDA but not of AMPA receptors. European Journal of Pharmacology. 262: R3-4. PMID 7813559 DOI: 10.1016/0014-2999(94)90049-3 |
0.339 |
|
| 1994 |
Laporte AM, Lima L, Gozlan H, Hamon M. Selective in vivo labelling of brain 5-HT1A receptors by [3H]WAY 100635 in the mouse. European Journal of Pharmacology. 271: 505-14. PMID 7705451 DOI: 10.1016/0014-2999(94)90812-5 |
0.412 |
|
| 1994 |
Hammond C, Crépel V, Gozlan H, Ben-Ari Y. Anoxic LTP sheds light on the multiple facets of NMDA receptors. Trends in Neurosciences. 17: 497-503. PMID 7531893 DOI: 10.1016/0166-2236(94)90140-6 |
0.364 |
|
| 1993 |
Kidd EJ, Laporte AM, Langlois X, Fattaccini CM, Doyen C, Lombard MC, Gozlan H, Hamon M. 5-HT3 receptors in the rat central nervous system are mainly located on nerve fibres and terminals. Brain Research. 612: 289-98. PMID 8330206 DOI: 10.1016/0006-8993(93)91674-H |
0.44 |
|
| 1993 |
Kidd FJ, Levy JC, Nielsen M, Hamon M, Gozlan H. Characterisation of the non-5-HT3 high-affinity 'R' binding site for (R)-zacopride in brain and other tissues. European Journal of Pharmacology. 247: 45-56. PMID 8258360 DOI: 10.1016/0922-4106(93)90136-W |
0.42 |
|
| 1993 |
Bachy A, Héaulme M, Giudice A, Michaud JC, Lefevre IA, Souilhac J, Manara L, Emerit MB, Gozlan H, Hamon M. SR 57227A: a potent and selective agonist at central and peripheral 5-HT3 receptors in vitro and in vivo. European Journal of Pharmacology. 237: 299-309. PMID 7689975 DOI: 10.1016/0014-2999(93)90282-M |
0.446 |
|
| 1993 |
Jolas T, Haj-Dahmane S, Lanfumey L, Fattaccini CM, Kidd EJ, Adrien J, Gozlan H, Guardiola-Lemaitre B, Hamon M. (-)Tertatolol is a potent antagonist at pre- and postsynaptic serotonin 5-HT1A receptors in the rat brain. Naunyn-Schmiedeberg's Archives of Pharmacology. 347: 453-63. PMID 7686633 DOI: 10.1007/Bf00166735 |
0.464 |
|
| 1993 |
Miquel M-, Emerit MB, Gingrich JA, Gozlan H, Hamon M. 22 - Solubilization and Physicochemical Characterization of 5-HT3 Receptor-Binding Sites Methods in Neurosciences. 11: 375-397. DOI: 10.1016/B978-0-12-185271-9.50027-7 |
0.438 |
|
| 1993 |
Mestikawy SE, Emerit MB, Miquel MC, Gozlan H, Hamon M. Pharmacological and biochemical properties of central 5-HT3 and 5-HT4 receptors European Neuropsychopharmacology. 3: 245-246. DOI: 10.1016/0924-977X(93)90053-O |
0.39 |
|
| 1992 |
Schlicker E, Werner U, Hamon M, Gozlan H, Nickel B, Szelenyi I, Göthert M. Anpirtoline, a novel, highly potent 5-HT1B receptor agonist with antinociceptive/antidepressant-like actions in rodents. British Journal of Pharmacology. 105: 732-8. PMID 1628159 DOI: 10.1111/J.1476-5381.1992.Tb09047.X |
0.355 |
|
| 1992 |
Kidd E, Bouchelet de Vendegies I, Levy JC, Hamon M, Gozlan H. The potent 5-HT3 receptor antagonist (R)-zacopride labels an additional high affinity site in the central nervous system. European Journal of Pharmacology. 211: 133-6. PMID 1618262 DOI: 10.1016/0014-2999(92)90276-A |
0.363 |
|
| 1992 |
Laporte AM, Koscielniak T, Ponchant M, Vergé D, Hamon M, Gozlan H. Quantitative autoradiographic mapping of 5-HT3 receptors in the rat CNS using [125I]iodo-zacopride and [3H]zacopride as radioligands. Synapse (New York, N.Y.). 10: 271-81. PMID 1585260 DOI: 10.1002/Syn.890100402 |
0.433 |
|
| 1992 |
Martin P, Gozlan H, Puech AJ. 5-HT3 receptor antagonists reverse helpless behaviour in rats. European Journal of Pharmacology. 212: 73-8. PMID 1532555 DOI: 10.1016/0014-2999(92)90074-E |
0.396 |
|
| 1992 |
Matthiessen L, Daval G, Bailly Y, Gozlan H, Hamon M, Vergé D. Quantification of 5-hydroxytryptamine1A receptors in the cerebellum of normal and X-irradiated rats during postnatal development. Neuroscience. 51: 475-85. PMID 1465205 DOI: 10.1016/0306-4522(92)90331-U |
0.378 |
|
| 1992 |
Metzenauer P, Barnes NM, Costall B, Gozlan H, Hamon M, Kelly ME, Murphy DA, Naylor RJ. Anxiolytic-like actions of anpirtoline in a mouse light-dark aversion paradigm. Neuroreport. 3: 527-9. PMID 1356500 DOI: 10.1097/00001756-199206000-00019 |
0.325 |
|
| 1992 |
Merahi N, Orer HS, Laporte AM, Gozlan H, Hamon M, Laguzzi R. Baroreceptor reflex inhibition induced by the stimulation of serotonin3 receptors in the nucleus tractus solitarius of the rat. Neuroscience. 46: 91-100. PMID 1350667 DOI: 10.1016/0306-4522(92)90011-P |
0.379 |
|
| 1992 |
Dumuis A, Gozlan H, Sebben M, Ansanay H, Rizzi CA, Turconi M, Monferini E, Giraldo E, Schiantarelli P, Ladinsky H. Characterization of a novel 5-HT4 receptor antagonist of the azabicycloalkyl benzimidazolone class: DAU 6285. Naunyn-Schmiedeberg's Archives of Pharmacology. 345: 264-9. PMID 1320204 DOI: 10.1007/Bf00168685 |
0.421 |
|
| 1991 |
Radja F, Laporte AM, Daval G, Vergé D, Gozlan H, Hamon M. Autoradiography of serotonin receptor subtypes in the central nervous system. Neurochemistry International. 18: 1-15. PMID 20504669 DOI: 10.1016/0197-0186(91)90029-D |
0.387 |
|
| 1991 |
el Mestikawy S, Fargin A, Raymond JR, Gozlan H, Hnatowich M. The 5-HT1A receptor: an overview of recent advances. Neurochemical Research. 16: 1-10. PMID 2052135 DOI: 10.1007/Bf00965820 |
0.404 |
|
| 1991 |
Miquel MC, Emerit MB, Gozlan H, Hamon M. Involvement of tryptophan residue(s) in the specific binding of agonists/antagonists to 5-HT3 receptors in NG108-15 clonal cells. Biochemical Pharmacology. 42: 1453-61. PMID 1930269 DOI: 10.1016/0006-2952(91)90459-I |
0.454 |
|
| 1991 |
Emerit MB, Miquel MC, Gozlan H, Hamon M. The GTP-insensitive component of high-affinity [3H]8-hydroxy-2-(di-n-propylamino)tetralin binding in the rat hippocampus corresponds to an oxidized state of the 5-hydroxytryptamine1A receptor. Journal of Neurochemistry. 56: 1705-16. PMID 1826520 DOI: 10.1111/J.1471-4159.1991.Tb02071.X |
0.385 |
|
| 1991 |
Fattaccini CM, Gozlan H, Hamon M. Differential effects of d-fenfluramine and p-chloroamphetamine on H75/12-induced depletion of 5-hydroxytryptamine and dopamine in the rat brain. Neuropharmacology. 30: 15-23. PMID 1710793 DOI: 10.1016/0028-3908(91)90037-C |
0.363 |
|
| 1991 |
Laporte AM, Schechter LE, Bolaños FJ, Vergé D, Hamon M, Gozlan H. [3H]5-methyl-urapidil labels 5-HT1A receptors and alpha 1-adrenoceptors in the rat CNS. In vitro binding and autoradiographic studies. European Journal of Pharmacology. 198: 59-67. PMID 1680714 DOI: 10.1016/0014-2999(91)90562-5 |
0.395 |
|
| 1991 |
Gozlan H, Saddiki-Traki F, Merahi N, Laguzzi R, Hamon M. [Preclinical pharmacology of amoxapine and amitriptyline. Implications of serotoninergic and opiodergic systems in their central effect in rats]. L'EncéPhale. 17: 415-22. PMID 1666997 |
0.357 |
|
| 1991 |
Riad M, Mestikawy SE, Verge D, Gozlan H, Hamon M. Visualization and quantification of central 5-HT1A receptors with specific antibodies Neurochemistry International. 19: 413-423. DOI: 10.1016/0197-0186(91)90058-L |
0.419 |
|
| 1991 |
Ponchant M, Koscielniak T, Hamon M, Gozlan H. Synthesis of 5-[125I]-iodo-zacopride, a new probe for 5-HT3 receptor binding sites Journal of Labelled Compounds and Radiopharmaceuticals. 29: 1147-1155. DOI: 10.1002/Jlcr.2580291007 |
0.379 |
|
| 1990 |
Sotelo C, Cholley B, El Mestikawy S, Gozlan H, Hamon M. Direct Immunohistochemical Evidence of the Existence of 5-HT1A Autoreceptors on Serotoninergic Neurons in the Midbrain Raphe Nuclei. The European Journal of Neuroscience. 2: 1144-1154. PMID 12106075 DOI: 10.1111/J.1460-9568.1990.Tb00026.X |
0.38 |
|
| 1990 |
Gozlan H, Daval G, Verge D, Spampinato U, Fattaccini CM, Gallissot MC, el Mestikawy S, Hamon M. Aging associated changes in serotoninergic and dopaminergic pre- and postsynaptic neurochemical markers in the rat brain. Neurobiology of Aging. 11: 437-49. PMID 2381503 DOI: 10.1016/0197-4580(90)90011-N |
0.41 |
|
| 1990 |
Hamon M, Gozlan H, el Mestikawy S, Emerit MB, Bolaños F, Schechter L. The central 5-HT1A receptors: pharmacological, biochemical, functional, and regulatory properties. Annals of the New York Academy of Sciences. 600: 114-29; discussion 1. PMID 2252305 DOI: 10.1111/J.1749-6632.1990.Tb16877.X |
0.343 |
|
| 1990 |
Bolaños FJ, Schechter LE, Miquel MC, Emerit MB, Rumigny JF, Hamon M, Gozlan H. Common pharmacological and physico-chemical properties of 5-HT3 binding sites in the rat cerebral cortex and NG 108-15 clonal cells. Biochemical Pharmacology. 40: 1541-50. PMID 2222509 DOI: 10.1016/0006-2952(90)90452-Q |
0.427 |
|
| 1990 |
Miquel MC, Emerit MB, Bolaños FJ, Schechter LE, Gozlan H, Hamon M. Physicochemical properties of serotonin 5-HT3 binding sites solubilized from membranes of NG 108-15 neuroblastoma-glioma cells. Journal of Neurochemistry. 55: 1526-36. PMID 2213008 DOI: 10.1111/J.1471-4159.1990.Tb04935.X |
0.412 |
|
| 1990 |
el Mestikawy S, Riad M, Laporte AM, Vergé D, Daval G, Gozlan H, Hamon M. Production of specific anti-rat 5-HT1A receptor antibodies in rabbits injected with a synthetic peptide. Neuroscience Letters. 118: 189-92. PMID 2148816 DOI: 10.1016/0304-3940(90)90623-H |
0.371 |
|
| 1990 |
Emerit MB, el Mestikawy S, Gozlan H, Rouot B, Hamon M. Physical evidence of the coupling of solubilized 5-HT1A binding sites with G regulatory proteins. Biochemical Pharmacology. 39: 7-18. PMID 2136995 DOI: 10.1016/0006-2952(90)90642-X |
0.31 |
|
| 1990 |
Koscielniak T, Ponchant M, Laporte AM, Guminski Y, Verge D, Hamon M, Gozlan H. [(125I)iodo-zacopride: new ligand for the study by autoradiography of central 5-HT3 receptors]. Comptes Rendus De L'AcadéMie Des Sciences. SéRie Iii, Sciences De La Vie. 311: 231-7. PMID 2121314 |
0.351 |
|
| 1990 |
Hamon M, Lanfumey L, el Mestikawy S, Boni C, Miquel MC, Bolaños F, Schechter L, Gozlan H. The main features of central 5-HT1 receptors. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 3: 349-60. PMID 2078271 |
0.32 |
|
| 1990 |
Schechter LE, Bolaños FJ, Gozlan H, Lanfumey L, Haj-Dahmane S, Laporte AM, Fattaccini CM, Hamon M. Alterations of central serotoninergic and dopaminergic neurotransmission in rats chronically treated with ipsapirone: biochemical and electrophysiological studies. The Journal of Pharmacology and Experimental Therapeutics. 255: 1335-47. PMID 1702155 |
0.347 |
|
| 1990 |
Fattaccini CM, Bolaños-Jimenez F, Gozlan H, Hamon M. Tianeptine stimulates uptake of 5-hydroxytryptamine in vivo in the rat brain. Neuropharmacology. 29: 1-8. PMID 1689469 DOI: 10.1016/0028-3908(90)90076-4 |
0.4 |
|
| 1990 |
Hamon M, Emerit MB, Mestikawy Se, Gallissot MC, Gozlan H. Regional differences in the transduction mechanisms of 5-hydroxytryptamine receptors in the mammalian brain Developments in Cardiovascular Medicine. 106: 41-59. DOI: 10.1007/978-94-009-0479-8_4 |
0.417 |
|
| 1989 |
Hamon M, Gallissot MC, Menard F, Gozlan H, Bourgoin S, Vergé D. 5-HT3 receptor binding sites are on capsaicin-sensitive fibres in the rat spinal cord. European Journal of Pharmacology. 164: 315-22. PMID 2759179 DOI: 10.1016/0014-2999(89)90472-X |
0.403 |
|
| 1989 |
Hoyer D, Gozlan H, Bolanos F, Schechter LE, Hamon M. Interaction of psychotropic drugs with central 5-HT3 recognition sites: fact or artifact? European Journal of Pharmacology. 171: 137-9. PMID 2612568 DOI: 10.1016/0014-2999(89)90438-X |
0.389 |
|
| 1989 |
Gozlan H, Schechter LE, Bolanos F, Emerit MB, Miquel MC, Nielsen M, Hamon M. Determination of the molecular size of the 5-HT3 receptor binding site by radiation inactivation. European Journal of Pharmacology. 172: 497-500. PMID 2533081 DOI: 10.1016/0922-4106(89)90033-3 |
0.438 |
|
| 1989 |
el Mestikawy S, Taussig D, Gozlan H, Emerit MB, Ponchant M, Hamon M. Chromatographic analyses of the serotonin 5-HT1A receptor solubilized from the rat hippocampus. Journal of Neurochemistry. 53: 1555-66. PMID 2529352 DOI: 10.1111/J.1471-4159.1989.Tb08552.X |
0.411 |
|
| 1989 |
Adrien J, Lanfumey L, Gozlan H, Fattaccini CM, Hamon M. Biochemical and electrophysiological evidence for an agonist action of CM 57493 at pre- and postsynaptic 5-hydroxytryptamine1A receptors in brain. The Journal of Pharmacology and Experimental Therapeutics. 248: 1222-30. PMID 2522986 |
0.365 |
|
| 1988 |
el Mestikawy S, Cognard C, Gozlan H, Hamon M. Pharmacological and biochemical characterization of rat hippocampal 5-hydroxytryptamine1A receptors solubilized by 3-[3-(cholamidopropyl)dimethylammonio]-1-propane sulfonate (CHAPS). Journal of Neurochemistry. 51: 1031-40. PMID 2971097 DOI: 10.1111/J.1471-4159.1988.Tb03064.X |
0.401 |
|
| 1988 |
Scherman D, Hamon M, Gozlan H, Henry JP, Lesage A, Masson M, Rumigny JF. Molecular pharmacology of niaprazine. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 12: 989-1001. PMID 2853885 DOI: 10.1016/0278-5846(88)90093-0 |
0.415 |
|
| 1988 |
Hamon M, Fattaccini CM, Adrien J, Gallissot MC, Martin P, Gozlan H. Alterations of central serotonin and dopamine turnover in rats treated with ipsapirone and other 5-hydroxytryptamine1A agonists with potential anxiolytic properties. The Journal of Pharmacology and Experimental Therapeutics. 246: 745-52. PMID 2457083 |
0.31 |
|
| 1988 |
Spampinato U, Gozlan H, Daval G, Fattaccini CM, Hamon M. Dopamine receptor subsensitivity in the substantia nigra after chronic morphine treatment in rats. European Journal of Pharmacology. 150: 113-22. PMID 2456939 DOI: 10.1016/0014-2999(88)90756-X |
0.387 |
|
| 1987 |
Emerit MB, el Mestikawy S, Gozlan H, Cossery JM, Besselievre R, Marquet A, Hamon M. Identification of the 5-HT1A receptor binding subunit in rat brain membranes using the photoaffinity probe [3H]8-methoxy-2-[N-n-propyl, N-3-(2-nitro-4-azidophenyl)aminopropyl]aminotetralin. Journal of Neurochemistry. 49: 373-80. PMID 3598578 DOI: 10.1111/J.1471-4159.1987.Tb02875.X |
0.415 |
|
| 1987 |
Daval G, Vergé D, Becerril A, Gozlan H, Spampinato U, Hamon M. Transient expression of 5-HT1A receptor binding sites in some areas of the rat CNS during postnatal development. International Journal of Developmental Neuroscience : the Official Journal of the International Society For Developmental Neuroscience. 5: 171-80. PMID 2972174 DOI: 10.1016/0736-5748(87)90027-X |
0.444 |
|
| 1987 |
Cossery JM, Gozlan H, Spampinato U, Perdicakis C, Guillaumet G, Pichat L, Hamon M. The selective labelling of central 5-HT1A receptor binding sites by [3H]5-methoxy-3-(di-n-propylamino)chroman. European Journal of Pharmacology. 140: 143-55. PMID 2959487 DOI: 10.1016/0014-2999(87)90800-4 |
0.435 |
|
| 1987 |
Gozlan H, Emerit MB, el Mestikawy S, Cossery JM, Marquet A, Besselievre R, Hamon M. Photoaffinity labelling and solubilization on the central 5-HT1A receptor binding site. Journal of Receptor Research. 7: 195-221. PMID 2957498 DOI: 10.3109/10799898709054986 |
0.34 |
|
| 1987 |
Aniksztejn L, Roisin MP, Gozlan H, Ben-Ari Y. Long-lasting potentiation produced by a phorbol ester in the hippocampus of the anaesthetized rat is not associated with a persistent enhanced release of excitatory amino acids. Neuroscience Letters. 81: 291-5. PMID 2893317 DOI: 10.1016/0304-3940(87)90398-3 |
0.323 |
|
| 1986 |
Gozlan H, Emerit MB, Hall MD, Nielsen M, Hamon M. In situ molecular sizes of the various types of 5-HT binding sites in the rat brain. Biochemical Pharmacology. 35: 1891-7. PMID 3718534 DOI: 10.1016/0006-2952(86)90308-4 |
0.416 |
|
| 1986 |
Hall MD, Gozlan H, Emerit MB, el Mestikawy S, Pichat L, Hamon M. Differentiation of pre- and post-synaptic high affinity serotonin receptor binding sites using physico-chemical parameters and modifying agents. Neurochemical Research. 11: 891-912. PMID 3016581 DOI: 10.1007/Bf00965212 |
0.423 |
|
| 1986 |
Vergé D, Daval G, Marcinkiewicz M, Patey A, el Mestikawy S, Gozlan H, Hamon M. Quantitative autoradiography of multiple 5-HT1 receptor subtypes in the brain of control or 5,7-dihydroxytryptamine-treated rats. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 6: 3474-82. PMID 2947981 DOI: 10.1523/Jneurosci.06-12-03474.1986 |
0.456 |
|
| 1986 |
Emerit MB, Gozlan H, Marquet A, Hamon M. Irreversible blockade of central 5-HT1A receptor binding sites by the photoaffinity probe 8-methoxy-3'-NAP-amino-PAT. European Journal of Pharmacology. 127: 67-81. PMID 2944752 DOI: 10.1016/0014-2999(86)90207-4 |
0.439 |
|
| 1986 |
Hamon M, Cossery JM, Spampinato U, Gozlan H. Are there selective ligands for 5-HT1A and 5-HT1B receptor binding sites in brain? Trends in Pharmacological Sciences. 7: 336-338. DOI: 10.1016/0165-6147(86)90377-9 |
0.368 |
|
| 1985 |
Hall MD, el Mestikawy S, Emerit MB, Pichat L, Hamon M, Gozlan H. [3H]8-hydroxy-2-(di-n-propylamino)tetralin binding to pre- and postsynaptic 5-hydroxytryptamine sites in various regions of the rat brain. Journal of Neurochemistry. 44: 1685-96. PMID 3157780 |
0.323 |
|
| 1985 |
Emerit MB, Gozlan H, Hall MD, Hamon M, Marquet A. Irreversible blockade of central 5-HT binding sites by 8-methoxy-2'-chloro-PAT. Biochemical Pharmacology. 34: 883-92. PMID 3156602 DOI: 10.1016/0006-2952(85)90762-2 |
0.319 |
|
| 1985 |
Verge D, Daval G, Patey A, Gozlan H, el Mestikawy S, Hamon M. Presynaptic 5-HT autoreceptors on serotonergic cell bodies and/or dendrites but not terminals are of the 5-HT1A subtype. European Journal of Pharmacology. 113: 463-4. PMID 2931289 DOI: 10.1016/0014-2999(85)90099-8 |
0.345 |
|
| 1984 |
Marcinkiewicz M, Vergé D, Gozlan H, Pichat L, Hamon M. Autoradiographic evidence for the heterogeneity of 5-HT1 sites in the rat brain Brain Research. 291: 159-163. PMID 6230136 DOI: 10.1016/0006-8993(84)90664-4 |
0.429 |
|
| 1984 |
Hamon M, Bourgoin S, Gozlan H, Hall MD, Goetz C, Artaud F, Horn AS. Biochemical evidence for the 5-HT agonist properties of PAT (8-hydroxy-2-(di-n-propylamino)tetralin) in the rat brain European Journal of Pharmacology. 100: 263-276. PMID 6203761 DOI: 10.1016/0014-2999(84)90002-5 |
0.304 |
|
| 1983 |
Gozlan H, El Mestikawy S, Pichat L, Glowinski J, Hamon M. Identification of presynaptic serotonin autoreceptors using a new ligand: 3H-PAT. Nature. 305: 140-2. PMID 6225026 DOI: 10.1038/305140a0 |
0.345 |
|
| Show low-probability matches. |